BioSante Pharmaceuticals, Inc.
BioSante Pharmaceuticals Reports Product Development Highlights and 2007 Financial Results
Published in Women's Health Weekly, April 3rd, 2008
"BioSante has had an exciting year and that excitement continues," said Stephen M. Simes, BioSante's president and chief executive officer. "We have made significant advances with the products in our pipeline, in particular with regard to LibiGel(R), our transdermal testosterone gel for the treatment of female sexual dysfunction (FSD). We reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) that sets in motion a process by which we are pursuing aggressively the Phase III clinical...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Chromosomal Abnormalities
Study links dietary folate intake to genetic abnormalities in sperm - Heart Disease
Women are treated less frequently than men with statins, aspirin and beta-blockers - HIV/AIDS
Researchers develop new tool to predict who will use microbicides - Osteoporosis
Gene variants associated with increased risk of bone fractures, low bone mineral density - Post-Traumatic Stress Disorders
Variations of stress response gene appear to be predictive of risk of PTSD - University of Texas at Austin
Do attractive women want it all? - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
